At the upcoming ACHEMA in Germany, the Romaco Group will be presenting its first anti-counterfeit solution for blister packs. The new system was developed exclusively with its partner company Nano 4 U and integrated into the Romaco Noack blister line 960.
Anti-counterfeiting technology is an extremely important issue for global pharmaceutical producers and packaging contractors. In an exclusive partnership with Nano 4 U, Romaco has developed an anti-counterfeit solution for blister packaging that is suitable for pharmaceutical products and meets the EU Falsified Medicine Directive 2011/62/EU. At ACHEMA, the company will be introducing the Romaco Noack 960 blister line with the new technology for unique primary packaging identification.
The new solution is based on a banknote authentication system. Romaco Nano 4 U took this technology further. The new system to protect the primary packaging of pharmaceutical solids can be integrated into all blister machines equipped with coding stations. An individual hologram stamp gives a unique indication of originality – in-line and without the use of additional materials. The individual blister packs are coded with overt and/or covert security features. Visible holograms with company logos, combinations of letters and digits, instantly identify the blister packs as originals. Invisible codes that can be verified quickly and easily can also be incorporated into the hologram. All that is needed for verification of a hidden logo or data matrix code, is a simple laser pointer.
The use of anti-counterfeit and high-precision stamps makes this technology a serious deterrent to counterfeiters. Whereas integrating the hologram stamp into the coding station of a Romaco Noack blister machine is very simple. The security features are applied using a heated coding tool without affecting production speed.
At the ACHEMA event, the Romaco Group will for the first time be showing how the Noack 960 blister line can produce anti-counterfeit blister packs with hologram stamps. The new solution also integrates future track & trace standards for the full traceability of pharmaceutical products.